- Home
- THAR vs XPON Comparison
THAR vs XPON Comparison
Compare THAR & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- XPON
- Stock Information
- Founded
- THAR 2017
- XPON 2016
- Country
- THAR United States
- XPON United States
- Employees
- THAR N/A
- XPON N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- THAR Health Care
- XPON Technology
- Exchange
- THAR Nasdaq
- XPON Nasdaq
- Market Cap
- THAR 3.3M
- XPON 3.2M
- IPO Year
- THAR 2022
- XPON 2022
- Fundamental
- Price
- THAR $1.82
- XPON $0.83
- Analyst Decision
- THAR Strong Buy
- XPON
- Analyst Count
- THAR 1
- XPON 0
- Target Price
- THAR $17.00
- XPON N/A
- AVG Volume (30 Days)
- THAR 41.7K
- XPON 54.1K
- Earning Date
- THAR 08-08-2025
- XPON 08-13-2025
- Dividend Yield
- THAR N/A
- XPON N/A
- EPS Growth
- THAR N/A
- XPON N/A
- EPS
- THAR N/A
- XPON N/A
- Revenue
- THAR N/A
- XPON $6,702,411.00
- Revenue This Year
- THAR N/A
- XPON $61.26
- Revenue Next Year
- THAR N/A
- XPON N/A
- P/E Ratio
- THAR N/A
- XPON N/A
- Revenue Growth
- THAR N/A
- XPON 23.07
- 52 Week Low
- THAR $0.95
- XPON $0.60
- 52 Week High
- THAR $6.39
- XPON $120.00
- Technical
- Relative Strength Index (RSI)
- THAR 64.36
- XPON 43.08
- Support Level
- THAR $1.30
- XPON $0.81
- Resistance Level
- THAR $1.46
- XPON $0.97
- Average True Range (ATR)
- THAR 0.14
- XPON 0.08
- MACD
- THAR 0.02
- XPON -0.01
- Stochastic Oscillator
- THAR 96.17
- XPON 18.57
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.